A detailed history of Kensington Investment Counsel, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Kensington Investment Counsel, LLC holds 30,872 shares of ABBV stock, worth $5.56 Million. This represents 2.56% of its overall portfolio holdings.

Number of Shares
30,872
Previous 30,556 1.03%
Holding current value
$5.56 Million
Previous $5.24 Million 16.34%
% of portfolio
2.56%
Previous 2.33%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$163.84 - $199.33 $51,773 - $62,988
316 Added 1.03%
30,872 $6.1 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $198,131 - $231,372
1,280 Added 4.37%
30,556 $5.24 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $271,054 - $308,841
1,696 Added 6.15%
29,276 $5.33 Million
Q4 2023

Feb 15, 2024

BUY
$137.6 - $154.97 $377,299 - $424,927
2,742 Added 11.04%
27,580 $4.27 Million
Q3 2023

Nov 09, 2023

BUY
$133.59 - $154.65 $104,600 - $121,090
783 Added 3.26%
24,838 $3.7 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $358,969 - $446,714
2,709 Added 12.69%
24,055 $3.24 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $403,172 - $464,313
-2,788 Reduced 11.55%
21,346 $3.4 Million
Q4 2022

Feb 15, 2023

BUY
$138.31 - $165.87 $45,780 - $54,902
331 Added 1.39%
24,134 $3.9 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $160,112 - $183,638
1,193 Added 5.28%
23,803 $3.2 Million
Q2 2022

Jul 15, 2022

SELL
$137.62 - $174.96 $55,048 - $69,984
-400 Reduced 1.74%
22,610 $3.46 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $3.04 Million - $3.77 Million
23,010 New
23,010 $3.73 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $2.89 Million - $3.58 Million
-21,861 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $31,691 - $40,099
295 Added 1.37%
21,861 $2.96 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $91,217 - $101,621
867 Added 4.19%
21,566 $2.43 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $257,079 - $283,014
2,513 Added 13.82%
20,699 $2.24 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $1.46 Million - $1.98 Million
18,186 New
18,186 $1.95 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Kensington Investment Counsel, LLC Portfolio

Follow Kensington Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kensington Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kensington Investment Counsel, LLC with notifications on news.